Sun J, Chen W, Xu H
BMC Pulm Med. 2025; 25(1):106.
PMID: 40057701
PMC: 11889936.
DOI: 10.1186/s12890-025-03556-6.
Bilbie-Lupchian L, Olivan-Blazquez B, Gonzalez-Alvarez B, Matovelle-Ochoa P, Casado-Vicente V, Sanchez-Calavera M
Prim Health Care Res Dev. 2025; 26:e26.
PMID: 40041980
PMC: 11883795.
DOI: 10.1017/S1463423625000155.
Chulenbayeva L, Issilbayeva A, Sailybayeva A, Bekbossynova M, Kozhakhmetov S, Kushugulova A
Biomedicines. 2025; 13(2).
PMID: 40002756
PMC: 11853371.
DOI: 10.3390/biomedicines13020343.
Valera-Arevalo G, Rodriguez-San Pedro M, Caro P, Cabanillas V, Ortiz-Diaz M, Figuer A
Antioxidants (Basel). 2025; 14(2).
PMID: 40002365
PMC: 11851666.
DOI: 10.3390/antiox14020178.
Liang M, Yang Q, Lu Y, Wang Y
Medicine (Baltimore). 2025; 104(7):e41567.
PMID: 39960925
PMC: 11835086.
DOI: 10.1097/MD.0000000000041567.
Combination therapy: an upcoming paradigm to improve kidney and cardiovascular outcomes in chronic kidney disease.
Alicic R, Neumiller J, Tuttle K
Nephrol Dial Transplant. 2025; 40(Supplement_1):i3-i17.
PMID: 39907543
PMC: 11795665.
DOI: 10.1093/ndt/gfae212.
Screening of biomarkers for diagnosing chronic kidney disease and heart failure with preserved ejection fraction through bioinformatics analysis.
Hou C, Xu J, Zhou M, Huo J, Wang X, Jiang W
Biochem Biophys Rep. 2025; 41:101911.
PMID: 39877037
PMC: 11773089.
DOI: 10.1016/j.bbrep.2024.101911.
DEPDC1B, CDCA2, APOBEC3B, and TYMS are potential hub genes and therapeutic targets for diagnosing dialysis patients with heart failure.
Tang W, Wang Z, Yuan X, Chen L, Guo H, Qi Z
Front Cardiovasc Med. 2025; 11():1442238.
PMID: 39844908
PMC: 11752391.
DOI: 10.3389/fcvm.2024.1442238.
Inferior vena cava diameter in patients with chronic heart failure and chronic kidney disease: a retrospective study.
Li J, Wang C, Dong H, Qi J, Rao C, Li Q
Eur J Med Res. 2025; 30(1):30.
PMID: 39810195
PMC: 11734577.
DOI: 10.1186/s40001-024-02264-x.
Type of arrhythmias and the risk of sudden cardiac death in dialysis patients: a systematic review and meta-analysis.
Chander S, Bin Aamir A, Latif R, Parkash O, Sorath F, Tan S
Egypt Heart J. 2025; 77(1):11.
PMID: 39804455
PMC: 11730032.
DOI: 10.1186/s43044-025-00606-6.
Medical Costs and Economic Impact of Hyperkalemia in a Cohort of Heart Failure Patients with Reduced Ejection Fraction.
Lopez-Lopez A, Regueiro-Abel M, Paredes-Galan E, Johk-Casas C, Vieitez-Florez J, Elices-Teja J
J Clin Med. 2025; 14(1.
PMID: 39797142
PMC: 11720833.
DOI: 10.3390/jcm14010058.
Cardiorenal Disease and Heart Failure with Preserved Ejection Fraction: Two Sides of the Same Coin.
Nunez-Marina G, Nunez-Marin G, Santas E
Cardiorenal Med. 2025; 15(1):108-121.
PMID: 39778558
PMC: 11844673.
DOI: 10.1159/000543390.
Angiotensin Receptor-Neprilysin Inhibitor in Heart Failure Patients With Renal Dysfunction.
Zhu X, Li X, Zhu L, Tong Z, Xu X
Cardiovasc Ther. 2025; 2024:6231184.
PMID: 39742017
PMC: 11554417.
DOI: 10.1155/2024/6231184.
Effect of heart failure and atrial fibrillation on cardiorespiratory fitness in hemodialysis patients.
Pella E, Boutou A, Boulmpou A, Theodorakopoulou M, Karagiannidis A, Haddad N
Int Urol Nephrol. 2024; 57(3):897-906.
PMID: 39467956
DOI: 10.1007/s11255-024-04260-w.
Kidney lesions and risk of cardiovascular events in biopsy-proven diabetic kidney disease with type 2 diabetes.
Shimizu M, Furuichi K, Toyama T, Yamanouchi M, Hayashi D, Koshino A
Clin Exp Nephrol. 2024; 29(3):376-386.
PMID: 39466582
DOI: 10.1007/s10157-024-02576-6.
Tolvaptan and the role of kidney aquaporin-2 abundance in managing volume overload in patients with CKD.
Yan Y, Li X, Yang Y, Wang F, Liu H, Tang R
Clin Kidney J. 2024; 17(10):sfae303.
PMID: 39449995
PMC: 11500452.
DOI: 10.1093/ckj/sfae303.
Urine Albumin-to-Creatinine Ratio as an Indicator of Brain Activity Changes in Chronic Kidney Disease: A Resting-State fMRI Study.
Yu Y, Zhang J, Wang Z, Li J, Hua X, Pan J
Brain Behav. 2024; 14(10):e70106.
PMID: 39417474
PMC: 11483559.
DOI: 10.1002/brb3.70106.
Looking for the ideal medication for heart failure with reduced ejection fraction: a narrative review.
Pascual-Figal D, Bayes-Genis A
Front Cardiovasc Med. 2024; 11:1439696.
PMID: 39314771
PMC: 11417622.
DOI: 10.3389/fcvm.2024.1439696.
Safety and efficacy of angiotensin receptor neprilysin inhibitor in improving cardiac function and blood pressure in dialysis patients.
Zhou K, Zhang Q, Dong W, Li X, Sun Y, Zhang Y
Front Med (Lausanne). 2024; 11:1421085.
PMID: 39301489
PMC: 11410709.
DOI: 10.3389/fmed.2024.1421085.
Research hotspots and future trends in lipid metabolism in chronic kidney disease: a bibliometric and visualization analysis from 2004 to 2023.
Wang Y, Liu T, Liu W, Zhao H, Li P
Front Pharmacol. 2024; 15:1401939.
PMID: 39290864
PMC: 11405329.
DOI: 10.3389/fphar.2024.1401939.